Beta-adrenoceptor blocking drug pharmacokinetics in hyperthyroidism. Therapeutic relevance

被引：0

作者：

Bouvier, N ^{[1
]}

Millart, H ^{[1
]}

机构：

[1] CHU, Hop Maison Blanche, Lab Pharmacol Toxicol, F-51092 Reims, France

来源：

THERAPIE | 1998年 / 53卷 / 06期

关键词：

hyperthyroidism; beta-blockers; pharmacokinetics; therapeutics;

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Hyperthyroidism is associated with alterations in pharmacokinetic parameters such as absorption, distribution, metabolism and elimination. Beta-blockers are used in particular in the treatment of hyperthyroidism and are also subject to pharmacokinetic changes occurring during this pathology. The magnitude of these variations is examined when beta-blockers are used for clinical manifestations of hyperthyroidism or during thyroid surgery. Clinical means used to assess the accuracy of therapeutic drug monitoring are also described.

引用

页码：523 / 531

页数：9

共 9 条

[1] BETA-ADRENOCEPTOR BLOCKING-DRUGS IN THE ELDERLY
TREGASKIS, BF
MCDEVITT, DG
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1990, 16 : S25 - S28
[2] CARDIAC BETA-ADRENOCEPTOR CHANGES IN EXPERIMENTAL HYPERTHYROIDISM IN DOGS
HOEY, A
BROWN, L
MARCHANT, C
ATWELL, R
SERNIA, C
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1992, 19 (11) : 761 - 766
[3] Pharmacokinetics of beta-adrenoceptor blockers in obese and normal volunteers
Cheymol, G
Poirier, JM
Carrupt, PA
Testa, B
Weissenburger, J
Levron, JC
Snoeck, E
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1997, 43 (06) : 563 - 570
[4] THE CHIRAL CHROMATOGRAPHIC-SEPARATION OF BETA-ADRENOCEPTOR BLOCKING-DRUGS
DYAS, AM
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 1992, 10 (06) : 383 - 404
[5] THE POSITION OF THE BETA-ADRENOCEPTOR BLOCKING-DRUGS IN CURRENT CLINICAL-PRACTICE
RUMBOLDT, Z
ZDRAVSTVENI VESTNIK, 1991, 60 (7-8): : 333 - 337
[6] BETA-ADRENOCEPTOR BLOCKING EFFECTS OF 2 BOPINDOLOL METABOLITES IN ISOLATED GUINEA-PIG ATRIA
BRASCH, H
DOMINIAK, P
ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1992, 42-1 (02): : 97 - 100
[7] THE EFFECT OF TOPICAL BETA-ADRENOCEPTOR BLOCKING-AGENTS ON PULSATILE OCULAR BLOOD-FLOW
MORSMAN, CD
BOSEM, ME
LUSKY, M
WEINREB, RN
EYE, 1995, 9 : 344 - 347
[8] BETA-ADRENOCEPTOR ANTAGONIST THERAPY IN HYPERTHYROIDISM - EFFECTS ON LYMPHOCYTE METABOLIC-ACTIVITY AND THE RELATION BETWEEN AEROBIC AND ANAEROBIC METABOLISM IN LYMPHOCYTES
VALDEMARSSON, S
MONTI, M
THERMOCHIMICA ACTA, 1995, 251 : 191 - 197
[9] Sirolimus Pharmacokinetics Variability Points to the Relevance of Therapeutic Drug Monitoring in Pediatric Oncology
Sabo, Amelia-Naomi
Jannier, Sarah
Becker, Guillaume
Lessinger, Jean-Marc
Entz-Werle, Natacha
Kemmel, Veronique
PHARMACEUTICS, 2021, 13 (04)

← 1 →